Novo Nordisk | Créanciers Commerciaux

Created with Highcharts 10.1.0Chart context menu


Trade Creditors Changement Date
ANI Pharmaceuticals USD 45.66M 15.23M 2024-12
Aurora Cannabis CAD 29.52M 20.78M 2024-12
Bausch Health Companies USD 667M 88M 2024-09
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Canopy Growth CAD 28.92M 3.43M 2024-12
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Drreddys Laboratories INR 36.02B 246M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
Merck USD 4.08B 493M 2024-12
Novartis USD 4.57B 485M 2024-12
Novo Nordisk 24.08B 5.68B 2024-09
Novo Nordisk DKK 24.08B 5.68B 2024-09
Pacira USD 19.13M 234K 2024-12
Perrigo USD 495.2M 36.7M 2024-12
Prestige Brands USD 19.51M 11.67M 2024-12
Sanofi 7.43B 105M 2024-06
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
Zoetis USD 433M 29M 2024-12



Novo Nordisk Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.